Purchase Order 75N94024P00697

Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $138K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $227,655 firm fixed price purchase order to Children's Hospital, a division of Children's National Medical Center, to support the development and implementation of the "Young At Heart Type 2 Diabetes Research Longitudinal Protocol." Per the solicitation, this involves protocol development, research services, and participant recruitment for the joint NIDDK/Children's Hospital...
This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Children's Research Institute, a subsidiary of the Children's National Medical Center, for $23,332.97. The contract is for research recruitment and services related to the NIDDK Youth and Young Adult Diabetes Research Program. The work will be performed in Washington, D.C. and has a completion date of September 27, 2023. This contract award does...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (HHS-NIH-NIDDK) awarded a firm fixed price purchase order valued at an undisclosed amount to Child Mind Institute Inc. of New York, New York. Under the award, Child Mind Institute will provide unspecified products or services in support of NIDDK's mission to conduct and support research and research training on diseases of national and international...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $25,000 purchase order contract to Build Clinical, LLC of New York, New York. Under the terms of the contract, Build Clinical will provide recruitment services to NIDDK for the period of September 18, 2023 through September 17, 2024. As the lead institute for diabetes, digestive, and kidney research within the Department of Health and Human Services, NIDDK seeks to accelerate...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases, a civilian federal agency, awarded a $22,811,246.05 definitive cost-no-fee contract to Childrens Hospital Medical Center (doing business as Children's Home Healthcare), a non-profit pediatric hospital and research center located in Cincinnati, Ohio. The contract is for research and development facilities and services, with a period of performance ending on March 31, 2010. This contract does not have a set-aside...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $8,574.06 firm fixed price purchase order to The AD Solution, Inc. to provide unspecified products or services in Bethesda, Maryland. The award period runs from August 31, 2016 through September 30, 2016. No additional details were provided regarding the original solicitation, association with any government-wide acquisition contracts or...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $125,000.00 firm fixed-price purchase order contract to The Children's Hospital of Philadelphia (CHOP) for the CHAIRPERSON OF THE GLOMERULAR DISEASE CONSORTIUM project. The contract has a base period with 4 option years, and the ultimate completion date is September 24, 2028. This contract was not set aside for any specific business category. CHOP is a leading pediatric hospital and research facility that...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $227,011.68 delivery order contract to Inode Ink Corporation Khai Huynh Division. This order was issued against the Chief Information Officer - Solutions and Partners 3 Small Business Government-Wide Acquisition Contract (CIO-SP3 SB GWAC) for the purpose of providing Infrastructure System...
This $180,000.00 firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Joslin Diabetes Center, Inc., a non-profit organization based in Boston, Massachusetts. The contract does not have a set-aside designation. The purpose of this award is to provide specialized research-related services and materials to support NIDDK's diabetes studies. Joslin...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $16,100 firm fixed price purchase order to Mary Cecelia Kirker doing business as Mary C Kirker. The place of performance will be in Rockville, Maryland. The period of performance is from July 13, 2023 to July 12, 2024. As the National Institute of Diabetes and Digestive and Kidney Diseases conducts research related to diabetes, digestive...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $138,294 firm fixed-price purchase order to Children's Hospital, a non-profit pediatric healthcare institution, for the Acquisition of Services for the Young At Heart Type 2 Diabetes Research Longitudinal Protocol. The contract, which has no set-aside designation, will support protocol development, research implementation and services, and participant recruitment for a joint NIDDK/National Institute of Child Health and Human Development (NICHD) program focused on type 2 diabetes research. Children's Hospital was determined to be the sole responsible source due to its expertise in pediatric care and serving a diverse population with type 2 diabetes. The period of performance is from September 16, 2024 to September 15, 2025, with the work to be performed at the National Institutes of Health (NIH) in Bethesda, Maryland.

Generated 9/17/24, 9:58 AM